<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">PP</journal-id><journal-title-group><journal-title>Pharmacology &amp; Pharmacy</journal-title></journal-title-group><issn pub-type="epub">2157-9423</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/pp.2014.57070</article-id><article-id pub-id-type="publisher-id">PP-46785</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>MEDICINE &amp; HEALTHCARE</subject><subject>CHEMISTRY &amp; MATERIALS SCIENCE</subject></subj-group></article-categories><title-group><article-title>Dietary Magnesium Intake Related to C-Reactive Protein in Newly Diagnosed Coronary Heart Disease Patients at Middle Zone, Gaza Strip. A Hospital Based Study</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jehad</surname><given-names>H. El-Hissi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Adham</surname><given-names>I. Ahmed</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ihab</surname><given-names>M. Al-Masri</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mazen</surname><given-names>A. El-Sakka</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Atef</surname><given-names>A. Masad</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ahmed</surname><given-names>A. Najem</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib></contrib-group><aff id="aff5"><addr-line>Faculty of Intermediate Studies, University of Palestine, Gaza, Palestine</addr-line></aff><aff id="aff1"><addr-line>Faculty of Medicine, Al-Azhar University, Gaza, Palestine</addr-line></aff><aff id="aff2"><addr-line>Al-Aqsa Martyr’s Hospital, Ministry of Health, Dier El-Balah, Palestine</addr-line></aff><aff id="aff3"><addr-line>Faculty of Pharmacy, Al-Azhar University, Gaza, Palestine</addr-line></aff><aff id="aff4"><addr-line>Faculty of Science, The Islamic University, Gaza, Palestine</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>Rn.Adham@gmail.com(AIA)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>06</month><year>2014</year></pub-date><volume>05</volume><issue>07</issue><fpage>601</fpage><lpage>611</lpage><history><date date-type="received"><day>8</day>	<month>February</month>	<year>2014</year></date>
<date date-type="rev-recd"><day>15</day>	<month>May</month>	<year>2014</year>	</date>


<date date-type="accepted"><day>4</day>	<month>June</month><year>2014</year></date>
</history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
	


	Coronary Heart
Disease (CHD) is a highly prevalent disease all over the world. Magnesium (Mg)
plays a role in CHD but it is still unclear. C-Reactive Protein (CRP) is an
inflammatory marker which may rise in CHD. Aim of study: To assess the impact
of dietary Mg intake and its level in relation to CRP among newly diagnosed
CHD at middle zone of Gaza Strip. Methodology: Patients (n = 140) with
confirmed CHD, 50 ± 10 years, presented in the cardiac care unit at Aqsa Martyr’s
Hospital between 1 April 2012 and 30 December 2012, were enrolled in this
cross-sectional study after taking consent. ECG, clinical status, and cardiac
markers were used to confirm diagnosis by cardiologist. Food frequency
questionnaire was used to assess Mg intake and calcium intake in addition to
measurement of its level in serum. CRP latex slide was used for measurement of
CRP. Results: Mg intake and serum Mg were<b> </b>inversely associated with risk<b> </b>of
CHD. Mean of serum Mg among cases (1.80) was
lower than controls (2.41) (P =
0.001). Percent of positive CRP was higher in cases (32.9%) than
controls (12.9%) (P = 0.005). Mean of
serum Mg was (1.96 ± 0.47) for positive CRP which
was lower than the mean of serum Mg (2.15 ± 0.44) for negative CRP. Conclusion:
Newly diagnosed patients with CHD have a positive CRP, low serum and low Mg intake, and low serum Mg was associated with
elevated CRP.
</p></abstract><kwd-group><kwd>Coronary Heart Disease</kwd><kwd> C-Reactive Protein</kwd><kwd> Magnesium</kwd><kwd> Dietary Behavior</kwd><kwd> Life Style</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Cardiovascular disease (CVD) is considered as the first leading cause of death in the world [<xref ref-type="bibr" rid="scirp.46785-ref1">1</xref>] . In 2008, ac- cording to the WHO, 17 million died due to CVDs, therefore it is considered as the top-leading cause of death among non-communicable diseases worldwide [<xref ref-type="bibr" rid="scirp.46785-ref2">2</xref>] .</p><p>Mg has a very important role in proper functioning of the human body, especially the cardiovascular system. Mg deficiency in the body is associated with different risk factors for CVDs and atherogenesis such as increas- ing oxidative stress, cytokine synthesis, nitrogen oxides and mediators of inflammation and adhesion molecules on microvascular endothelial cells [<xref ref-type="bibr" rid="scirp.46785-ref3">3</xref>] . A possible role of Mg in the etiology of ischemic heart disease is still not sufficiently clear and it is likely that several mechanisms are involved. Other studies demonstrate that increased intake of dietary Mg may lower blood triglyceride level and increase high-density lipoprotein [<xref ref-type="bibr" rid="scirp.46785-ref4">4</xref>] . Numerous studies pointed to an inverse relationship between Mg intake through diet and the incidence of CVD [<xref ref-type="bibr" rid="scirp.46785-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.46785-ref6">6</xref>] .</p><p>We hypothesized that this association might be explained, in part, by the anti-inflammatory properties of Mg [<xref ref-type="bibr" rid="scirp.46785-ref3">3</xref>] . Few studies revealed that individuals with intakes below the recommended dietary allowances are more likely to have elevated level of an inflammatory marker called CRP, which may contribute to CVD risk [<xref ref-type="bibr" rid="scirp.46785-ref7">7</xref>] .</p><p>To clarify these uncertainties, we examined the association between dietary and plasma Mg and risk of CHD among newly diagnosed CHD patients in the middle zone of the Gaza Strip. In addition to evaluate whether the association between Mg and CHD could be explained fully through traditional cardiovascular pathways, we used specific inclusion criteria.</p></sec><sec id="s2"><title>2. Subjects and Methods</title><sec id="s2_1"><title>2.1. Study Design</title><p>A case-control study was conducted in Al-Aqsa martyrs’ hospital, Dier Al-Balah. The type of this study design is used widely, often in epidemiology. It is a type of observational study in which two existing groups differing in outcome are identified and compared on the basis of some supposed causal attribute.</p></sec><sec id="s2_2"><title>2.2. Study Population and Sampling</title><p>The target population was hospitalized patients in cardiac care unit with CHD and patients and their fellows with- out any suspicion of CHD at other departments who are 50 &#177; 10 years. They were recruited according to the inclu- sion criteria in the study after getting their consent. A Purposeful, non-random sample included 140 participants divided into two groups according to the eligibility criteria. Participants were allocated into: Group A (n = 70) patients with newly diagnosed with CHD; Group B (n = 70) patients without any suspicion of CHD and their fellows.</p><sec id="s2_2_1"><title>Selection Criteria</title><p>Subjects who were eligible to participate in the study were those who met the following criteria.</p></sec></sec><sec id="s2_3"><title>2.3. Inclusion Criteria</title><sec id="s2_3_1"><title>• 2.3.1. Cases</title><p>• Patients diagnosed with acute CHD who are 50 &#177; 10 years.</p><p>• Evident ischemic ECG abnormalities.</p></sec><sec id="s2_3_2"><title>• 2.3.2. Controls</title><p>• Patients without CHD.</p><p>• Patients who 50 &#177; 10 years.</p><p>• No any history of health problem related to the heart.</p><p>• Normal ECG.</p></sec><sec id="s2_3_3"><title>• 2.3.3. Exclusion Criteria (for Cases and Controls)</title><p>• Those diagnosed with congestive heart failure, gastrointestinal disease, liver or kidney diseases, diabetes mellitus, hyperthyroidism or hyperparathyroidism.</p><p>• Patients post recent acute infection, recent trauma or surgical intervention.</p><p>• Those who were taking insulin preparations, vitamin-mineral supplements, hormone replacement therapy, or intake of any medication may cause hypomagnesaemia or hypomagnesaemia and also pregnant or lactating women.</p></sec></sec><sec id="s2_4"><title>2.4. End-Point Ascertainment and Definitions</title><p>CHD occurs when a substance called plaque builds up in coronary arteries that lead to arteriosclerosis which is leading-cause of myocardial ischemia and myocardial infarction [<xref ref-type="bibr" rid="scirp.46785-ref8">8</xref>] . Participants included were divided into cases and controls, and defined by cardiologists depending on clinical status, ECG, and biochemical investiga- tions included cardiac markers. Normal Mg level is (1.8 - 2.3) mg/dL. Hypomagnesaemia was considered when serum Mg level below (&lt;1.8) mg/dL. It was categorized into three levels including mild (1.6 - 1.8 mg/dL), mod- erate (1.3 - 1.5 mg/dL), and sever (&lt;1.2 mg/dL) [<xref ref-type="bibr" rid="scirp.46785-ref9">9</xref>] . Serum CRP level was determined using slide agglutination test and reference value was (up to 6 mg/L) [<xref ref-type="bibr" rid="scirp.46785-ref10">10</xref>] .</p></sec><sec id="s2_5"><title>2.5. Assessment of Dietary Magnesium Intake</title><p>Data on usual diet was ascertained by using the food frequency questionnaires. For each food item, each partici- pant was asked how often, on average, he/she had consumed a specified portion size over the past month. We made a list of the richest food of Mg available depending on the United States Agriculture Department (USDA) food database [<xref ref-type="bibr" rid="scirp.46785-ref11">11</xref>] . The t test was used to assess the difference of servings consumed among participants.</p></sec><sec id="s2_6"><title>2.6. Measurement of Biochemical Variables</title><p>Serum Mg and Calcium were detected by colorimetric methods in the serum of cases and controls by spectro- photometer machine with a kit from (DiaSys Diagnostic Systems GmbH—Germany) [<xref ref-type="bibr" rid="scirp.46785-ref23">23</xref>] , and also serum CRP was measured by the latex agglutination machine with a kit from (Inmesco GmbH—Germany) CRP latex slide test (serology kit) is used for the semi-quantitative measurement [<xref ref-type="bibr" rid="scirp.46785-ref24">24</xref>] .</p></sec><sec id="s2_7"><title>2.7. Assessment of Coronary Heart Disease</title><p>Cardiologists were selected the new cases with CHD and confirmed the diagnosis of CHD on the basis of the criteria of the WHO (symptoms plus either diagnostic ECG changes or elevated levels of cardiac enzymes) [<xref ref-type="bibr" rid="scirp.46785-ref25">25</xref>] .</p></sec><sec id="s2_8"><title>2.8. Assessment of Other Factors</title><p>Lifestyle and dietary data were derived from the questionnaire administered. Intake of saturated-fat food was assessed by a short fat questionnaire designed by Australian Journal of Public Health [<xref ref-type="bibr" rid="scirp.46785-ref12">12</xref>] . Average of Mg rich food intake was computed with the use of a semi quantitative food-frequency questionnaire. The questionnaires were validated by a specialists and face validity was used for other measurements.</p></sec><sec id="s2_9"><title>2.9. Statistical Analysis</title><p>Statistical Package for the Social Sciences (SPSS) program version 19 [<xref ref-type="bibr" rid="scirp.46785-ref13">13</xref>] was used for data analysis which in- cludes cross tabulations of the results and Chi square test for categorical data, odds ratio and the confidence in- terval was the statistical tool used to assess the association between family members, income per month, and family history, smoking status, exposure to others smoke, and clinical manifestations of hypomagnesaemia. T- test for quantitative data analysis was used to compare means of serum Mg, Calcium and CRP levels between cases and controls. P value was used for measuring statistical difference between discrete variables.</p></sec><sec id="s2_10"><title>2.10. Ethical Consideration</title><p>We get all of required ethical approvals including dean of postgraduate studies &amp; research affairs, dean of col- lege of pharmacy, Ministry of Health and informed consent of the participants.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Baseline Characteristics of Participants</title><p>Regarding the gender, it was noticed that the percent of male gender (62.1%) was higher than females (37.9%) among all the participants and among cases and controls. However, no statistically significant difference was found between cases and controls regarding the gender of participants (P = 0.222).</p><p>The mean ages of study population were 51.69 &#177; 5.7 years and 49.86 &#177; 6.8 years for case and controls, re- spectively. The mean age of male participants was 50.36 (&#177;6.5) years and for females was 51.45 (&#177;6.0) years. Participants’ age was divided into three categories one of them is less than 45 years old, from 45 to 55 years and more than 55 years. The majority of participants’ age was from 45 - 55 years (48.6%) as shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>Education level of participants was categorized into illiterate, basic, secondary, “diploma or bachelor” and “master or PhD”. According to the results obtained in <xref ref-type="table" rid="table2">Table 2</xref>, the percent of participants who have “diploma or bachelor” degree was the highest among participants (41.4%). On the other hand, the percent of cases having</p><table-wrap id="table1"  position="float"><object-id pub-id-type="pii">Table 1</object-id><label>Table 1</label><caption><p>. Personal and socioeconomic characteristics of participants.</p></caption><table><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Cases No (%)</th><th align="center" valign="middle" >Controls No (%)</th><th align="center" valign="middle" >Total</th><th align="center" valign="middle" >P Value</th></tr></thead><tbody><tr><td align="center" valign="middle"  colspan="5"  >Gender</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >47 (67.1%)</td><td align="center" valign="middle" >40 (57.1%)</td><td align="center" valign="middle" >87 (62.1%)</td><td align="center" valign="middle"  rowspan="2"  >0.222</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >23 (32.9%)</td><td align="center" valign="middle" >30 (42.9%)</td><td align="center" valign="middle" >53 (37.9%)</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Age</td></tr><tr><td align="center" valign="middle" >Less than 45 Years</td><td align="center" valign="middle" >10 (14.3%)</td><td align="center" valign="middle" >22 (31.4%)</td><td align="center" valign="middle" >32 (22.9%)</td><td align="center" valign="middle"  rowspan="3"  >0.048<sup>*</sup></td></tr><tr><td align="center" valign="middle" >From 45 - 55 Years</td><td align="center" valign="middle" >39 (55.7%)</td><td align="center" valign="middle" >29 (41.4%)</td><td align="center" valign="middle" >68 (48.6%)</td></tr><tr><td align="center" valign="middle" >More than 55 Years</td><td align="center" valign="middle" >21 (30.0%)</td><td align="center" valign="middle" >19 (27.1%)</td><td align="center" valign="middle" >40 (28.6%)</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Education Level</td></tr><tr><td align="center" valign="middle" >Illiterate</td><td align="center" valign="middle" >2 (2.9%)</td><td align="center" valign="middle" >1 (1.4%)</td><td align="center" valign="middle" >3 (2.1%)</td><td align="center" valign="middle"  rowspan="5"  >0.001<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Basic</td><td align="center" valign="middle" >17 (24.3%)</td><td align="center" valign="middle" >6 (8.6%)</td><td align="center" valign="middle" >23 (16.4%)</td></tr><tr><td align="center" valign="middle" >Secondary</td><td align="center" valign="middle" >30 (42.9%)</td><td align="center" valign="middle" >20 (28.6%)</td><td align="center" valign="middle" >50 (35.7%)</td></tr><tr><td align="center" valign="middle" >Diploma/Bachelor</td><td align="center" valign="middle" >19 (27.1%)</td><td align="center" valign="middle" >39 (57.7%)</td><td align="center" valign="middle" >58 (41.4%)</td></tr><tr><td align="center" valign="middle" >Master or PhD</td><td align="center" valign="middle" >2 (2.9%)</td><td align="center" valign="middle" >4 (5.7%)</td><td align="center" valign="middle" >6 (4.3%)</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Employment Status</td></tr><tr><td align="center" valign="middle" >Employed</td><td align="center" valign="middle" >17 (24.3%)</td><td align="center" valign="middle" >26 (37.1%)</td><td align="center" valign="middle" >43 (30.7%)</td><td align="center" valign="middle"  rowspan="3"  >0.167</td></tr><tr><td align="center" valign="middle" >Unemployed</td><td align="center" valign="middle" >35 (50.0%)</td><td align="center" valign="middle" >25 (35.7%)</td><td align="center" valign="middle" >60 (42.9%)</td></tr><tr><td align="center" valign="middle" >Self-Employed</td><td align="center" valign="middle" >18 (25.7%)</td><td align="center" valign="middle" >19 (27.1%)</td><td align="center" valign="middle" >37 (26.4%)</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Family Income</td></tr><tr><td align="center" valign="middle" >&lt;2$/day/capita</td><td align="center" valign="middle" >31 (44.3%)</td><td align="center" valign="middle" >17 (24.3%)</td><td align="center" valign="middle" >48 (34.3%)</td><td align="center" valign="middle"  rowspan="2"  >0.01<sup>*</sup></td></tr><tr><td align="center" valign="middle" >≥2$/day/capita</td><td align="center" valign="middle" >39 (55.7%)</td><td align="center" valign="middle" >53 (75.7%)</td><td align="center" valign="middle" >92 (65.7%)</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Family Members</td></tr><tr><td align="center" valign="middle" >Less than 5 Members</td><td align="center" valign="middle" >13 (18.6%)</td><td align="center" valign="middle" >23 (32.9%)</td><td align="center" valign="middle" >36 (25.7%)</td><td align="center" valign="middle"  rowspan="3"  >0.024<sup>*</sup></td></tr><tr><td align="center" valign="middle" >From 5 - 10 Members</td><td align="center" valign="middle" >50 (71.4%)</td><td align="center" valign="middle" >46 (65.7%)</td><td align="center" valign="middle" >96 (68.6%)</td></tr><tr><td align="center" valign="middle" >More than 10 Members</td><td align="center" valign="middle" >7 (10.0%)</td><td align="center" valign="middle" >1 (1.4%)</td><td align="center" valign="middle" >8 (5.7%)</td></tr></tbody></table></table-wrap><p><sup>*</sup>Statistically significant.</p><table-wrap id="table2"  position="float"><object-id pub-id-type="pii">Table 2</object-id><label>Table 2</label><caption><p>. Life style of participants.</p></caption><table><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Cases No (%)</th><th align="center" valign="middle" >Controls No (%)</th><th align="center" valign="middle" >Total</th><th align="center" valign="middle" >P Value</th></tr></thead><tbody><tr><td align="center" valign="middle"  colspan="5"  >Smoking Status</td></tr><tr><td align="center" valign="middle" >Smoker</td><td align="center" valign="middle" >39 (55.7%)</td><td align="center" valign="middle" >22 (31.4%)</td><td align="center" valign="middle" >61 (43.6%)</td><td align="center" valign="middle"  rowspan="2"  >0.004<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Non Smoker</td><td align="center" valign="middle" >31 (44.3%)</td><td align="center" valign="middle" >48 (68.6%)</td><td align="center" valign="middle" >79 (56.4%)</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Passive Smokers</td></tr><tr><td align="center" valign="middle" >Exposed to Other’s Smoke</td><td align="center" valign="middle" >30 (42.9%)</td><td align="center" valign="middle" >13 (18.6%)</td><td align="center" valign="middle" >43 (30.7%)</td><td align="center" valign="middle"  rowspan="2"  >0.002<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Non-Exposed to Other’s Smoke</td><td align="center" valign="middle" >40 (57.1%)</td><td align="center" valign="middle" >57 (81.4%)</td><td align="center" valign="middle" >97 (69.3%)</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Saturated Fat Consumption</td></tr><tr><td align="center" valign="middle" >Low to Moderate</td><td align="center" valign="middle" >20 (28.6%)</td><td align="center" valign="middle" >30 (42.9%)</td><td align="center" valign="middle" >50 (35.7%)</td><td align="center" valign="middle"  rowspan="3"  >0.045<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Moderate</td><td align="center" valign="middle" >30 (42.9%)</td><td align="center" valign="middle" >31 (44.3%)</td><td align="center" valign="middle" >61 (43.6%)</td></tr><tr><td align="center" valign="middle" >Moderate to High</td><td align="center" valign="middle" >20 (28.6%)</td><td align="center" valign="middle" >9 (12.9%)</td><td align="center" valign="middle" >29 (20.7%)</td></tr></tbody></table></table-wrap><p><sup>*</sup>Statistically significant.</p><p>“diploma or bachelor” degree (27.1%) was lower than controls (57.7%) and this difference was found to be sta- tistically significant (P = 0.001, <xref ref-type="table" rid="table1">Table 1</xref>).</p><p>The employment status was divided into 3 groups included employed, unemployed and self-employed partici- pants. According to the results shown in <xref ref-type="table" rid="table2">Table 2</xref>, most of the participants were unemployed (42.9%). Among cases, the percent of unemployment (50.0%) was higher than controls (35.7%), however, the difference was not statistically significant (P = 0.16, <xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Family income data was analyzed in a way to determine income per capita per day. Income per capita was grouped into two categories according to the poverty line endorsed by The World Bank: those with income of less than 2 American dollars ($) per day and those with 2 $ per day or more [<xref ref-type="bibr" rid="scirp.46785-ref14">14</xref>] .</p><p><xref ref-type="table" rid="table1">Table 1</xref> shows that the percentage of participants with two or more dollars per day (65.7%) is higher than other category (34.3%). In cases, the percent of participants with two or more dollars per day (55.7%) was high- er than those with daily income less than two dollars (44.3%). Nevertheless, the percent of cases with less than two dollars daily (44.3%) were higher than controls (24.3%) and this difference was statistically significant (P = 0.01).</p><p>The number of family members was categorized into three groups: less than five, from five to ten and more than ten members as shown in <xref ref-type="table" rid="table1">Table 1</xref>. The highest group of family members was between five to ten (68.6%).</p><p>The percentages of cases living with family of 5 - 10 members (71.4%) and more than 10 members (10.0%) were higher than controls (65.7% and 1.4%, respectively) and this difference was statistically significant (P = 0.024).</p><p>As shown in <xref ref-type="table" rid="table2">Table 2</xref>, the percent of smokers among cases (55.7%) was higher than controls (31.4%) and this difference was statistically significant (P = 0.004).</p><p>The percent of participants exposed to other’s smoke (30.7%) was found to be lower than non-exposed per- sons (69.3%). However, <xref ref-type="table" rid="table4">Table 4</xref> shows that the percent of exposure to other’s smoke among cases (42.9%) was higher than controls (31.4%) and this difference was statistically significant (P = 0.002).</p><p>The data collected in <xref ref-type="table" rid="table2">Table 2</xref> show that the majority of participants (43.6%) were consuming moderately saturated fat-rich food. The percent of participants who consumed saturated fat-rich food in “low to moderate” level was (35.7%), whereas those consumed “Moderate to High” level was (20.7%). In this study, the percent of cases who consumed “Moderate to High” saturated fat (28.6%) were higher than controls (12.9%). On the other hand, the percent of controls who consumed “Low to Moderate” saturated fat were (42.9%) higher than cases (28.6%) and these differences were found to be statistically significant (P = 0.045).</p><sec id="s3_1_1"><title>Hypertension</title><p>The collected data in <xref ref-type="table" rid="table3">Table 3</xref> show that the majority of participants had a family history of high blood pres- sure “Hypertension” (58.2%). However, family history of hypertension among cases (72.9%) was much higher than among controls (44.3%) and this disparity was statistically very significant (P = 0.001).</p><table-wrap id="table3"  position="float"><object-id pub-id-type="pii">Table 3</object-id><label>Table 3</label><caption><p>. Family history of participants.</p></caption><table><thead><tr><th align="center" valign="middle"  colspan="2"  >Variables</th><th align="center" valign="middle" >Cases No (%)</th><th align="center" valign="middle" >Controls No (%)</th><th align="center" valign="middle" >Total</th><th align="center" valign="middle" >P Value</th></tr></thead><tbody><tr><td align="center" valign="middle"  rowspan="2"  >Hypertension</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >51 (72.9%)</td><td align="center" valign="middle" >31 (44.3%)</td><td align="center" valign="middle" >82 (58.6%)</td><td align="center" valign="middle"  rowspan="2"  >0.001<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >19 (27.1%)</td><td align="center" valign="middle" >39 (55.7%)</td><td align="center" valign="middle" >58 (41.4%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >High Blood Cholesterol</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >21 (30.0%)</td><td align="center" valign="middle" >7 (10.0%)</td><td align="center" valign="middle" >28 (20%)</td><td align="center" valign="middle"  rowspan="2"  >0.003<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >49 (70.0%)</td><td align="center" valign="middle" >63 (90.0%)</td><td align="center" valign="middle" >112 (80%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Heart Diseases</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >34 (48.6%)</td><td align="center" valign="middle" >14 (20.0%)</td><td align="center" valign="middle" >48 (34.3%)</td><td align="center" valign="middle"  rowspan="2"  >0.000<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >36 (51.4%)</td><td align="center" valign="middle" >56 (80.0%)</td><td align="center" valign="middle" >92 (65.7%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Obesity</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >29 (41.4%)</td><td align="center" valign="middle" >18 (25.7%)</td><td align="center" valign="middle" >47 (33.6%)</td><td align="center" valign="middle"  rowspan="2"  >0.049<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >41 (58.6%)</td><td align="center" valign="middle" >52 (74.3%)</td><td align="center" valign="middle" >93 (66.4%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Diabetes Mellitus</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >34 (48.6%)</td><td align="center" valign="middle" >21 (30.0%)</td><td align="center" valign="middle" >55 (39.3%)</td><td align="center" valign="middle"  rowspan="2"  >0.024<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >36 (51.4%)</td><td align="center" valign="middle" >49 (70.0%)</td><td align="center" valign="middle" >85 (60.7%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Cancer</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >4 (5.7%)</td><td align="center" valign="middle" >7 (10.0%)</td><td align="center" valign="middle" >11 (7.9%)</td><td align="center" valign="middle"  rowspan="2"  >0.346</td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >66 (94.3%)</td><td align="center" valign="middle" >63 (90.0%)</td><td align="center" valign="middle" >129 (92.1%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Gastrointestinal Diseases</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >8 (11.4%)</td><td align="center" valign="middle" >3 (4.3%)</td><td align="center" valign="middle" >11 (7.9%)</td><td align="center" valign="middle"  rowspan="2"  >0.116</td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >62 (88.6%)</td><td align="center" valign="middle" >67 (95.7%)</td><td align="center" valign="middle" >129 (92.1%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Allergies or Asthma</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >9 (12.9%)</td><td align="center" valign="middle" >4 (5.7%)</td><td align="center" valign="middle" >13 (9.3%)</td><td align="center" valign="middle"  rowspan="2"  >0.145</td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >61 (87.1%)</td><td align="center" valign="middle" >66 (94.3%)</td><td align="center" valign="middle" >127 (90.7%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Psychological Disorders</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >1 (1.4%)</td><td align="center" valign="middle" >4 (5.7%)</td><td align="center" valign="middle" >5 (3.6%)</td><td align="center" valign="middle"  rowspan="2"  >0.172</td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >69 (98.6%)</td><td align="center" valign="middle" >66 (94.3%)</td><td align="center" valign="middle" >135 (96.4%)</td></tr></tbody></table></table-wrap><p><sup>*</sup>Statistically significant.</p></sec><sec id="s3_1_2"><title>High blood cholesterol</title><p>The results shown in <xref ref-type="table" rid="table3">Table 3</xref> demonstrate that there is a statistically significance difference between cases and controls regarding the family history of high blood cholesterol (P = 0.003) as the number of cases with family history of high cholesterol (21) was higher than controls (7).</p></sec><sec id="s3_1_3"><title>Heart diseases</title><p>The percent of cases with family history of heart disease (48.6%) was statistically much higher than controls (20%) (P = 0.000) as shown in <xref ref-type="table" rid="table3">Table 3</xref>.</p></sec><sec id="s3_1_4"><title>Obesity</title><p>A statistically significant difference was found between cases and controls regarding family history of obesity (P = 0.049) as shown in <xref ref-type="table" rid="table3">Table 3</xref>. The percent among cases (41.4%) is higher than controls (25.7%).</p></sec><sec id="s3_1_5"><title>Diabetes mellitus</title><p>It’s noticed that the percent of cases with family history of diabetes mellitus (48.6%) is higher than controls (30.0%) and this disparity was found to be statistically significant (P = 0.024, <xref ref-type="table" rid="table3">Table 3</xref>).</p></sec><sec id="s3_1_6"><title>Other diseases</title><p>The results of this study revealed that there is no statistically significance difference between cases and con- trols regarding other diseases such as cancer, gastrointestinal disease, allergies, asthma and psychological dis- orders (P &gt; 0.05, <xref ref-type="table" rid="table3">Table 3</xref>).</p></sec></sec><sec id="s3_2"><title>3.2. Clinical Cutoff Points for Magnesium</title><sec id="s3_2_1"><title>3.2.1. Magnesium-Rich Food Intake</title><p>Independent t-test was used to compare the means of the number of servings of different types of food rich with Mg. In our study, it was found that cases consumed more servings of cabbage, while controls consumed more servings of molokhia, okra, potatoes and tomatoes. However, there was no statistically significant difference between cases and controls regarding the servings of different vegetables consumed by participants (P &gt; 0.05). Also, the results were revealed that there is no significant difference between cases and controls regarding the means of servings of dates, raisins, banana and grapes consumed by participants (P &gt; 0.05). On the other hand, there was a statistically significant difference between the means of servings consumed of melons and apples.</p><p>Regarding to grains, nuts, seeds and legumes the results shown that the number of servings of whole meal bread and cooked bulgur were higher in control than cases. However, only the bulgur intake difference was sta- tistically significant (P &lt; 0.05). On the other hand, the number of servings of white bread was higher in cases than controls, however this difference was not statistically significant (P = 0.761). Regarding the intake of nuts and seeds, it was found that controls consumed more servings of watermelon seeds, pumpkin seeds, sesame seeds; sunflower seeds; cashew; pistachio; peanut; chocolate; tahini in comparison to cases and these differences were found to be statistically significant except for pistachio, peanut and tahini (P &gt; 0.05). On the other hand, the intake of almond was slightly higher in cases than controls but without statistical significance (P = 0.543). It was found that cases consumed more servings of legumes (beans and lentils) than controls; however, this dif- ference was not statistically significant (P &gt; 0.05). There was no significant difference between cases and con- trols regarding the consumption of coffee (P = 0.828). The mean of servings of cocoa consumed by controls was higher than cases that reached to be statistically significant (P = 0.002). The mean of servings of whole milk consumed by controls was higher than cases and this difference was statistically significant (P = 0.092).</p></sec><sec id="s3_2_2"><title>3.2.2. Serum Magnesium</title><p>The participants were divided into three groups according to their serum Mg level: low (&lt;1.8) mg/dL, normal (1.8 - 2.3) mg/dL and high (&gt;2.3) mg/dL. The results obtained in revealed 48.6% of cases have low serum Mg level when compared with 4.3% of controls with statistical significant difference (P = 0.001, <xref ref-type="table" rid="table4">Table 4</xref>). The mean of Mg level among the cases (1.80) was found to be lower than the controls (2.41) and these differences were of high statistical significance (P = 0.001) as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p><p><xref ref-type="fig" rid="fig2">Figure 2</xref> shows the total participants with serum Mg level low (&lt;1.8) mg/dL were 37, hypomagnesmia was categorized into three levels including mild (1.6 - 1.8 mg/dL) represented 45.9%, moderate (1.3 - 1.5 mg/dL) represented 45.9%, and sever (&lt;1.2 mg/dL) represented 8.10%.</p></sec></sec><sec id="s3_3"><title>3.3. Association between Serum Magnesium and C-Reactive Protein</title><p><xref ref-type="table" rid="table5">Table 5</xref> revealed that 22.9% of participants have positive CRP while, 77.1% of them have negative CRP; the</p><table-wrap id="table4"  position="float"><object-id pub-id-type="pii">Table 4</object-id><label>Table 4</label><caption><p>. Clinical cutoff points for serum magnesium among participants.</p></caption><table><thead><tr><th align="center" valign="middle"  colspan="2"  >Variables</th><th align="center" valign="middle" >Cases No (%)</th><th align="center" valign="middle" >Controls No (%)</th><th align="center" valign="middle" >Total</th><th align="center" valign="middle" >P value</th></tr></thead><tbody><tr><td align="center" valign="middle"  rowspan="4"  >Serum Magnesium</td><td align="center" valign="middle" >Low (&lt;1.8) mg/dL</td><td align="center" valign="middle" >34 (48.6%)</td><td align="center" valign="middle" >3 (4.3%)</td><td align="center" valign="middle" >37 (26.4%)</td><td align="center" valign="middle"  rowspan="4"  >0.001<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Normal (1.8 - 2.3) mg/dL</td><td align="center" valign="middle" >31 (44.3%)</td><td align="center" valign="middle" >21 (30.0%)</td><td align="center" valign="middle" >52 (37.1%)</td></tr><tr><td align="center" valign="middle" >High (&gt;2.3) mg/dL</td><td align="center" valign="middle" >5 (7.1%)</td><td align="center" valign="middle" >46 (65.7%)</td><td align="center" valign="middle" >51 (36.4%)</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >70 (100%)</td><td align="center" valign="middle" >70 (100%)</td><td align="center" valign="middle" >140 (100%)</td></tr></tbody></table></table-wrap><p><sup>*</sup>Statistically significant (P-value &lt; 0.05).</p><fig id="fig1"><label>Figure 1</label><caption><p> The mean of serum Mg level among participants</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://file.scirp.org/Html/htmlimages\1-2500448x\dd3588c9-79f3-489e-99cc-4518d8257989.png"/></fig><p>mean of serum Mg was (1.96 &#177; 0.47) for positive CRP participants which was lower than the mean of serum Mg (2.15 &#177; 0.44) for negative CRP participants, with statistical significance (P = 0.03).</p></sec><sec id="s3_4"><title>3.4. Clinical Cutoff Points for C-Reactive Protein</title><p>The data collected showed that 32.9% of cases have positive CRP results when compared with 12.9% of con- trols and this difference was statistically significant (P = 0.005) as shown in <xref ref-type="table" rid="table6">Table 6</xref>.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>In this retrospective case control study, we found a modest inverse association between dietary Mg intake and serum Mg in relation to risk of CHD that did reach statistical significance. Percent of cases with low ‎Serum ‎Mg was (‎48.6%‎) ‎which is ‎higher than controls (‎4.3%‎) ‎ and the mean of serum ‎Mg ‎of participants among cases was (1.80 mg/dL) lower than ‎controls (2.41 mg/dL) (P = 0.001). ‎‎The result of present study agrees with the study ‎of ‎(Altura et al., 2007)‎ that concluded Mg deficiency in the body is associated with ‎different risk factors for CVDs and atherogenesis such as increasing ‎oxidative stress, cytokine synthesis, ‎nitrogen oxides and media- tors of inflammation and ‎adhesion molecules on microvascular ‎endothelial cells.‎</p><p>Authors [<xref ref-type="bibr" rid="scirp.46785-ref15">15</xref>] sought to investigate the relationship between dietary ‎Mg intake and mortality due to CVD in population-based sample ‎of Asian adults. Reported findings are based on dietary Mg intake in 58,615 ‎healthy Japanese aged 40 - 79 years, in Japan Collaborative Cohort (JACC) Study. Dietary Mg intake was assessed by a validated food frequency questionnaire ‎administered between 1988 and 1990. During the median 14.7-year fol- low-up, authors was ‎documented 2690 deaths due to CVD, comprising 1227 deaths from ‎strokes and 557 deaths of CHD. They was concluded that dietary Mg intake was ‎inversely associated with mortality from hemorrhagic stroke in men and with mortality ‎from total and ischemic strokes, CHD, heart failure and total CVD ‎especially in women.‎</p><fig id="fig2"><label>Figure 2</label><caption><p> Levels of hypomagnesaemia among participants</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://file.scirp.org/Html/htmlimages\1-2500448x\d56b593e-8ffb-4750-b5a8-446458b707a0.png"/></fig><table-wrap id="table5"  position="float"><object-id pub-id-type="pii">Table 5</object-id><label>Table 5</label><caption><p>. Independent t test comparing the means of Mg and CRP.</p></caption><table><thead><tr><th align="center" valign="middle"  colspan="2"  >Variable</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Mean</th><th align="center" valign="middle" >SD</th><th align="center" valign="middle" >t</th><th align="center" valign="middle" >P Value</th></tr></thead><tbody><tr><td align="center" valign="middle"  rowspan="2"  >CRP</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >108 (77.1%)</td><td align="center" valign="middle" >2.15</td><td align="center" valign="middle" >0.44</td><td align="center" valign="middle" >2.10</td><td align="center" valign="middle"  rowspan="2"  >0.03</td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >32 (22.9%)</td><td align="center" valign="middle" >1.96</td><td align="center" valign="middle" >0.47</td><td align="center" valign="middle" >2.02</td></tr></tbody></table></table-wrap><table-wrap id="table6"  position="float"><object-id pub-id-type="pii">Table 6</object-id><label>Table 6</label><caption><p>. Clinical cutoff points for C-reactive protein.</p></caption><table><thead><tr><th align="center" valign="middle"  colspan="2"  >Variables</th><th align="center" valign="middle" >Cases No (%)</th><th align="center" valign="middle" >Controls No (%)</th><th align="center" valign="middle" >Total</th><th align="center" valign="middle" >P Value</th></tr></thead><tbody><tr><td align="center" valign="middle"  rowspan="3"  >C-RP</td><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >23 (32.9%)</td><td align="center" valign="middle" >9 (12.9%)</td><td align="center" valign="middle" >32 (22.9%)</td><td align="center" valign="middle"  rowspan="3"  >0.005<sup>*</sup></td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >47 (67.1%)</td><td align="center" valign="middle" >61 (87.1%)</td><td align="center" valign="middle" >108 (77.1%)</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >70 (100%)</td><td align="center" valign="middle" >70 (100%)</td><td align="center" valign="middle" >140 (100%)</td></tr></tbody></table></table-wrap><p>The deficiency of Mg may be caused by eating cooked and processed food which is ‎considered as a common dietary habit among people of Gaza Strip, this proved by ‎‎Swaminathan [<xref ref-type="bibr" rid="scirp.46785-ref16">16</xref>] who reported cooking, especially boiling of Mg-rich food ‎results in significant loss of Mg and also [<xref ref-type="bibr" rid="scirp.46785-ref17">17</xref>] who reported that the ‎intake of processed and cooked is highly prevalent in many populations with low Mg ‎intake.‎ Low serum Mg reflects low dietary in- take of Mg which was more evident among cases, depending on the literature review there is association be- tween low Mg intake and risk factors for CVD, atherogenesis, increasing mediators of inflammation, and adhe- sion molecules on microvascular endothelial cells including coronary arteries which provides blood supply to the heart. Furthermore, low dietary Mg intake is associated with increased triglyceride and low-density lipo- protein (LDL) cholesterol levels which are considered as strong indicator for development of CHD.</p><p>We found ‎a direct strong relationship ‎between ‎CRP ‎and the development of CHD, in which the percent of cases with positive CRP‎ was (32.9%) higher than controls (12.9%). There was statistically significant ‎relationship that may explained by a role of inflammatory process during the development of CHD. ‎The result of present study agrees with the study of [<xref ref-type="bibr" rid="scirp.46785-ref18">18</xref>] that ‎concluded Mg depletion to be associated with elevated ‎hs-CRP ‎levels, suggesting that hypomagnesaemia and low-grade inflammation are ‎interactive risk ‎factors. In addition, it agrees with the cohort study conducted by [<xref ref-type="bibr" rid="scirp.46785-ref19">19</xref>] ‎which included 1653 adults ‎and revealed a relationship between lower Mg and ‎fiber intakes and increased level of hs-CRP.</p><p>We found ‎an inverse relationship ‎between‎ Mg and CRP, in which 22.9% of participants have positive CRP while, 77.1% of them have negative CRP; the mean of serum Mg was (1.96 &#177; 0.47) for positive CRP partici- pants which was lower than the mean of serum Mg (2.15 &#177; 0.44) for negative CRP participants, without statis- tical significance.‎ The result of present study agrees with the study of Guerrero-Romero &amp; Rodr&#237;guez-Mor&#225;n‎ [<xref ref-type="bibr" rid="scirp.46785-ref20">20</xref>] that ‎concluded low serum Mg levels are independently related to elevated CRP concentration. In addition it agrees with the context of a review article titled with “Mg: Novel Applications in CVD—A Review of the Lite- rature” which authored by [<xref ref-type="bibr" rid="scirp.46785-ref21">21</xref>] ‎ focused on the relationship between‎ Mg and CRP and concluded that hypomag- nesaemia results in increased CRP and platelet dysfunction, which can lead to thrombosis.</p><p>We found ‎a direct strong relationship ‎between‎ Serum ‎Ca ‎and ‎development of CHD, which the percent of cases with low Serum Ca ‎was (7.1%) ‎higher than controls (1.4%) ‎with ‎statistical significance (P = 0.011). The result of ‎present study contradicts with (Lu, et al., 2012) who concluded that the results of ‎their study were inconsistent and the pooled data do not strongly support a significant ‎effect of greater dietary Ca intake on the risk of CAD. On the other hand, many studies revealed association between the effects of hypomagnesmia over Ca in the body that leads to hypocalcaemia. Studies showed that a reduction in extracellular Mg concentration stimulated the secretion of parathyroid hormone (PTH) in the absence of changes in Ca concentration [<xref ref-type="bibr" rid="scirp.46785-ref22">22</xref>] .</p></sec><sec id="s5"><title>5. Conclusion</title><p>In conclusion, we found that decreased Mg intake was possibly associated with a higher risk of CHD among adults. Whereas the causal effect of Mg is not certain. In spite of that there is sufficient reason to encourage a balanced diet rich in Mg sources, such as whole grains, nuts, fruits and vegetables which are protective against the risk of CHD.</p></sec><sec id="s6"><title>Acknowledgements</title><p>We are very much thankful to the deanship of postgraduate studies &amp; research affairs of Al-Azhar University, deanship of college of pharmacy, ministry of health, Al-Aqsa martyrs’ hospital, special thanks to my uncle in law Mr. Tayseer Ahmed, my friend Mr. Mohammed Najem “Lab. technician” and to the team of Intensive Car- diac Care Unit for their ‎cooperation and assistance in data collection. Finally, I would thank all the patients and volunteers who participated in this study. To all of these individuals I owe many thanks for their insights and unlimited support.</p><p>&lt; </p></sec><sec id="s7"><title>NOTES@endMarkP#wang#_title:ep!!!</title><disp-formula id="scirp.46785-formula1"><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://file.scirp.org/Html/htmlimages\1-2500448x\8a7fa52b-e595-4496-a30f-4013a58cb127.png"/></disp-formula><p><sup>*</sup>Corresponding author.</p></sec></body><back><ref-list><title>References</title><ref id="scirp.46785-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>BERNARD</surname><given-names> J.G.</given-names></name>,<name name-style="western"><surname> SLIWA</surname><given-names> K.</given-names></name>,<name name-style="western"><surname> MAYOSI</surname><given-names> B.M. </given-names></name>,<name name-style="western"><surname> YUSUF</surname><given-names> S. </given-names></name>,<etal>et al</etal>. (<year>2010</year>)<article-title>THEEPIDEMIC OF CARDIOVASCULAR DISEASE IN THE DEVELOPING WORLD: GLOBAL IMPLICATIONS</article-title><source> EUROPEAN HEART JOURNAL</source><volume> 31</volume>,<fpage> 642</fpage>-<lpage>648</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1093/EURHEARTJ/EHQ030</pub-id></mixed-citation></ref><ref id="scirp.46785-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2012) GLOBAL HEALTH OBSERVATORY (GHO) DEATHS FROM CVD SITUATION.HTTP://WWW.WHO.INT/GHO/NCD/MORTALITY_MORBIDITY/CVD/EN/INDEX.HTML</mixed-citation></ref><ref id="scirp.46785-ref3"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ALTURA</surname><given-names> B.M. </given-names></name>,<name name-style="western"><surname> ALTURA</surname><given-names> B.T. </given-names></name>,<etal>et al</etal>. (<year>2007</year>)<article-title>MAGNESIUM: FORGOTTEN MINERAL IN CARDIOVASCULAR BIOLOGY AND ATHEROGENESIS. IN: NISHIZAWA, Y., MORII, H., DURLACH, J., EDS</article-title><source></source><volume> NEW PERSPECTIVES IN MAGNESIUM RESEARCH: NUTRITION AND HEALTH</volume>,<fpage> SPRINGER</fpage>-<lpage>VERLAG</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1007/978-1-84628-483-0_19</pub-id></mixed-citation></ref><ref id="scirp.46785-ref4"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SINGH</surname><given-names> R.B.</given-names></name>,<name name-style="western"><surname> RASTOGI</surname><given-names> S.S.</given-names></name>,<name name-style="western"><surname> SHARMA</surname><given-names> V.K.</given-names></name>,<name name-style="western"><surname> SAHARIA</surname><given-names> R.B. </given-names></name>,<name name-style="western"><surname> KULSRETHA</surname><given-names> S.K. </given-names></name>,<etal>et al</etal>. (<year>1990</year>)<article-title>SINGH, R.B., RASTOGI, S.S., SHARMA, V.K., SAHARIA, R.B. AND KULSRETHA, S.K</article-title><source>  CAN DIETARY MAGNESIUM MODULATE LIPOPROTEIN METABOLISM? MAGNESIUM AND TRACE ELEMENTS</source><volume> 9</volume>,<fpage> 255</fpage>-<lpage>264</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46785-ref5"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>AL-DELAIMY</surname><given-names> W.K.</given-names></name>,<name name-style="western"><surname> RIMM</surname><given-names> E.B. </given-names></name>,<name name-style="western"><surname> WILLETT</surname><given-names> W.C. </given-names></name>,<etal>et al</etal>. (<year>2004</year>)<article-title>MAGNESIUM INTAKE AND RISK OF CORONARY HEART DISEASE AMONG MEN</article-title><source> JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION</source><volume> 23</volume>,<fpage> 63</fpage>-<lpage>70</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1080/07315724.2004.10719344</pub-id></mixed-citation></ref><ref id="scirp.46785-ref6"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>BO</surname><given-names> S. </given-names></name>,<name name-style="western"><surname> PISU</surname><given-names> E. </given-names></name>,<etal>et al</etal>. (<year>2008</year>)<article-title>ROLE OF DIETARY MAGNESIUM IN CARDIOVASCULAR DISEASE PREVENTION, INSULIN SENSITIVITY AND DIABETES</article-title><source> CURRENT OPINION IN LIPIDOLOGY</source><volume> 19</volume>,<fpage> 50</fpage>-<lpage>56</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1097/MOL.0B013E3282F33CCC</pub-id></mixed-citation></ref><ref id="scirp.46785-ref7"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KING</surname><given-names> D.E.</given-names></name>,<name name-style="western"><surname> MAINOUS 3RD</surname><given-names> A.G.</given-names></name>,<name name-style="western"><surname> GEESEY</surname><given-names> M.E. </given-names></name>,<name name-style="western"><surname> WOOLSON</surname><given-names> R.F. </given-names></name>,<etal>et al</etal>. (<year>2005</year>)<article-title>DIETARY MAGNESIUM AND C-REACTIVE PROTEIN LEVELS</article-title><source> JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION</source><volume> 24</volume>,<fpage> 166</fpage>-<lpage>171</lpage>.<pub-id pub-id-type="doi">HTTP://DX.DOI.ORG/10.1080/07315724.2005.10719461</pub-id></mixed-citation></ref><ref id="scirp.46785-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">CDC (2012) ABOUT CORONARY ARTERY DISEASE, USA, 2013. HTTP://WWW.CDC.GOV/HEARTDISEASE/CORONARY_AD.HTM</mixed-citation></ref><ref id="scirp.46785-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">HALE, A. AND HOVEY, M. (2013) FLUID, ELECTROLYTE, AND ACID-BASE IMBALANCES: CONTENT REVIEW PLUS PRACTICE QUESTIONS (DAVISPLUS). DAVIS, PHILADELPHIA, 300-303.</mixed-citation></ref><ref id="scirp.46785-ref10"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KAO</surname><given-names> P.C.</given-names></name>,<name name-style="western"><surname> SHIESH</surname><given-names> S.C. </given-names></name>,<name name-style="western"><surname> WU</surname><given-names> T.J. </given-names></name>,<etal>et al</etal>. (<year>2006</year>)<article-title>KAO, P.C., SHIESH, S.C. AND WU, T.J.  SERUM C-REACTIVE PROTEIN AS A MARKER FOR WELLNESS ASSESSMENT</article-title><source> ANNALS OF CLINICAL AND LABORATORY SCIENCE</source><volume> 36</volume>,<fpage> 163</fpage>-<lpage>169</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46785-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">USDA (2013) AGRICULTURAL RESEARCH SERVICE. NUTRIENT INTAKES PERCENT OF POPULATION 2 YEARS OLD AND OVER WITH ADEQUATE INTAKES BASED ON AVERAGE REQUIREMENT. COMMUNITY NUTRITION MAPPING PROJECT.HTTP://WWW.ARS.USDA.GOV/BA/BHNRC/NDL</mixed-citation></ref><ref id="scirp.46785-ref12"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DOBSON</surname><given-names> A.J.</given-names></name>,<name name-style="western"><surname> BLIJLEVENS</surname><given-names> R.</given-names></name>,<name name-style="western"><surname> ALEX</surname><given-names>ER</given-names></name>,<name name-style="western"><surname> H.M.</surname><given-names> ET AL. </given-names></name>,<etal>et al</etal>. (<year>1993</year>)<article-title>DOBSON, A.J., BLIJLEVENS, R., ALEXANDER, H.M., ET AL.  SHORT FAT QUESTIONNAIRE: A SELF-ADMINISTERED MEASURE OF FAT-INTAKE BEHAVIOUR</article-title><source> AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH</source><volume> 17</volume>,<fpage> 144</fpage>-<lpage>149</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46785-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">IBM (2013) SPSS STATISTICS, USA, 2013.HTTP://WWW-01.IBM.COM/SOFTWARE/ANALYTICS/SPSS/PRODUCTS/STATISTICS/</mixed-citation></ref><ref id="scirp.46785-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">THE WORLD BANK (2013) POVERTY HEADCOUNT RATIO AT $2 A DAY (PPP) (% OF POPULATION), USA, 2005.HTTP://DATA.WORLDBANK.ORG/INDICATOR/SI.POV.2DAY</mixed-citation></ref><ref id="scirp.46785-ref15"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ZHANG</surname><given-names> W.</given-names></name>,<name name-style="western"><surname> ISO</surname><given-names> H.</given-names></name>,<name name-style="western"><surname> OHIRA</surname><given-names> T.</given-names></name>,<name name-style="western"><surname> DATE</surname><given-names> C. </given-names></name>,<name name-style="western"><surname> TAMAKOSHI</surname><given-names> A. </given-names></name>,<etal>et al</etal>. (<year>JACC STUDY GROUP</year>)<article-title>ZHANG, W., ISO, H., OHIRA, T., DATE, C. AND TAMAKOSHI, A.  (2012) ASSOCIATIONS OF DIETARY MAGNESIUM INTAKE WITH MORTALITY FROM CARDIOVASCULAR DISEASE: THE JACC STUDY</article-title><source> ATHEROSCLEROSIS</source><volume> 221</volume>,<fpage> 587</fpage>-<lpage>595</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46785-ref16"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>SWAMINATHAN</surname><given-names> R. </given-names></name>,<etal>et al</etal>. (<year>2003</year>)<article-title>MAGNESIUM METABOLISM AND ITS DISORDERS</article-title><source> CLINICAL BIOCHEMISTRY REVIEW</source><volume> 24</volume>,<fpage> 47</fpage>-<lpage>66</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46785-ref17"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>BO</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> DURAZZO</surname><given-names> M. </given-names></name>,<name name-style="western"><surname> GUIDI</surname><given-names> S. </given-names></name>,<etal>et al</etal>. (<year>2006</year>)<article-title>BO, S., DURAZZO, M. AND GUIDI, S.  DIETARY MAGNESIUM AND FIBER INTAKE, INFLAMMATORYAND METABOLIC PARAMETERS IN MIDDLE-AGED SUBJECTS FROM A POPULATION-BASED COHORT</article-title><source> THE AMERICAN JOURNAL OF CLINICAL NUTRITION</source><volume> 84</volume>,<fpage> 1062</fpage>-<lpage>1069</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46785-ref18"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>RODRÍGUEZ-MORÁN</surname><given-names> M. </given-names></name>,<name name-style="western"><surname> GUERRERO-ROMERO</surname><given-names> F. </given-names></name>,<etal>et al</etal>. (<year>2008</year>)<article-title>RODRÍGUEZ-MORÁN, M. AND GUERRERO-ROMERO, F.  SERUM MAGNESIUM AND C-REACTIVE PROTEIN LEVELS</article-title><source> ARCHIVES OF DISEASE IN CHILDHOOD</source><volume> 93</volume>,<fpage> 676</fpage>-<lpage>680</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46785-ref19"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>BO</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> DURAZZO</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> GUIDI</surname><given-names> S.</given-names></name>,<name name-style="western"><surname> CARELLO</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> SACERDOTE</surname><given-names> C.</given-names></name>,<name name-style="western"><surname> SILLI</surname><given-names> B.</given-names></name>,<name name-style="western"><surname> ROSATO</surname><given-names> R.</given-names></name>,<name name-style="western"><surname> CASSADER</surname><given-names> M.</given-names></name>,<name name-style="western"><surname> GENTILE</surname><given-names> L. </given-names></name>,<name name-style="western"><surname> PAGANO</surname><given-names> G. </given-names></name>,<etal>et al</etal>. (<year>2006</year>)<article-title>BO, S., DURAZZO, M., GUIDI, S., CARELLO, M., SACERDOTE, C., SILLI, B., ROSATO, R., CASSADER, M., GENTILE, L. AND PAGANO, G.  DIETARY MAGNESIUM AND FIBER INTAKES AND INFLAMMATORY AND METABOLIC INDICATORS IN MIDDLEAGED SUBJECTS FROM A POPULATION-BASED COHORT</article-title><source> THE AMERICAN JOURNAL OF CLINICAL NUTRITION</source><volume> 84</volume>,<fpage> 1062</fpage>-<lpage>1069</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46785-ref20"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>ROMERO</surname><given-names> G. </given-names></name>,<name name-style="western"><surname> MORÁN</surname><given-names> R. </given-names></name>,<etal>et al</etal>. (<year>2002</year>)<article-title>ROMERO, G. AND MORÁN, R.  RELATIONSHIP BETWEEN SERUM MAGNESIUM LEVELS AND C-REACTIVE PROTEIN CONCENTRATION, IN NON-DIABETIC, NON-HYPERTENSIVE OBESE SUBJECTS</article-title><source> INTERNATIONAL JOURNAL OF OBESITY</source><volume> 26</volume>,<fpage> 469</fpage>-<lpage>474</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46785-ref21"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>KUPETSKY-RINCON</surname><given-names> E. </given-names></name>,<name name-style="western"><surname> UITTO</surname><given-names> J. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>KUPETSKY-RINCON, E. AND UITTO, J.  MAGNESIUM: NOVEL APPLICATIONS IN CARDIOVASCULAR DISEASE—A REVIEW OF THE LITERATURE</article-title><source> ANNALS OF NUTRITION AND METABOLISM</source><volume> 61</volume>,<fpage> 102</fpage>-<lpage>110</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.46785-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">AGUS, Z.S. (1999) HYPOMAGNESEMIA. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 10, 1616-1622.HTTP://WWW.NCBI.NLM.NIH.GOV/PUBMED/10405219</mixed-citation></ref><ref id="scirp.46785-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">ANONYMOUS (2014) COMPACT VERSION—DIASYS DIAGNOSTIC SYSTEMS GMBH, GERMANY.HTTP://WWW.DIASYS-DIAGNOSTICS.COM/FILEADMIN/DOWNLOADS/PRINT_MATERIAL/KATALOG/DIASYS_SHORTCATALOGUE_2014_ENG.PDF</mixed-citation></ref><ref id="scirp.46785-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">ANONYMOUS (2014) CRP-LATEX AGGLUTINATION TEST—INMESCO GMBH, GERMANY.HTTP://WWW.INMESCO.DE/PDF/CUSTOMER-SUPPORT/RAPID-LATEX-SLIDE-TEST/INMESCO-CRP-LATEX-AGGLUTINATION-TEST.PDF</mixed-citation></ref><ref id="scirp.46785-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">ANONYMOUS (1979) NOMENCLATURE AND CRITERIA FOR DIAGNOSIS OF ISCHEMIC HEART DISEASE. REPORT OF THE JOINT INTERNATIONAL SOCIETY AND FEDERATION OF CARDIOLOGY/WORLD HEALTH ORGANIZATION TASK FORCE ON STANDARDIZATION OF CLINICAL NOMENCLATURE. CIRCULATION, 59, 607-609.</mixed-citation></ref></ref-list></back></article>